Generac Roars, AutoNation Sinks, Ultragenyx Jumps on New FDA Approval | Stock Movers

By Bloomberg Podcasts

Community Score: 50% | 626 views | 4w

0 community ratings: null thumbs up, null thumbs down

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Generac (GNRC) agreed to supply up to $8 billion worth of generators for Amazon.com Inc.’s data centers and issued a warrant for a stake in the company, according to a securities filing Wednesday. Shares of the US maker of backup power generators surged as much as 32% on Thursday, the biggest intraday increase in more than 14 years. The stock traded 19% higher at $208.36 as of 11:40 a.m. in New York. Shares of AutoNation (AN) dropped on Thursday, putting the stock on track for its worst decline since July 2023. A representative of the firm said at the Morgan Stanley Laguna Conference that customers are being more selective. Ultragenyx (RARE) shares jumped as much as 13%, the most intraday since June 30,after the firm got FDA approval for its gene therapy to treat pediatric patients with a rare inherited disease that progressively damages the brain and nervous system. See omnystudio.com/listener (

Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast

More from Bloomberg Podcasts

  • Follow the Money All the Way to Carney's Canada — Score: 50%
  • Daybreak Weekend: US CPI, Europe Energy, RBA Decision | Bloomberg Daybreak: Europe Edition — Score: 50%
  • Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase | Bloomberg Intelligence — Score: 50%
  • We hear you! | Bloomberg Hot Pursuit! — Score: 50%
  • Bloomberg Businessweek Weekend - August 7th, 2026 | Bloomberg Businessweek — Score: 50%
  • Team Favorite: AI-Era Internet, Spaceport Investment, Bolivia’s Investability | Wall Street Week — Score: 50%